Virtu Financial’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Virtu Financial’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,896	Closed	-$109K	–	2357
2023 Q4	$109K	Buy	+10,896	New	+$49.4K	0.01%	1012

Virtu Financial's GRCL Position: Q1 2024 in Review

Virtu Financial sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 10,896 shares — an estimated $109K sold.

Virtu Financial first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $109K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

Virtu Financial reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Virtu Financial sold 10,896 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $109K.
Virtu Financial first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
Virtu Financial's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $109K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.